Mohammad Rafiqul Mowla, MBBS, MD - Chittagong Medical College - Associate Professor

Mohammad Rafiqul Mowla

MBBS, MD

Chittagong Medical College

Associate Professor

Chittagong, Chittagong | Bangladesh

Main Specialties: Dermatology, Dermatopathology, Epidemiology, Rheumatology

ORCID logohttps://orcid.org/0000-0003-4138-2896


Top Author

Mohammad Rafiqul Mowla, MBBS, MD - Chittagong Medical College - Associate Professor

Mohammad Rafiqul Mowla

MBBS, MD

Introduction

Dr. Mohammad Rafiqul Mowla received his MBBS, MD (Dermatology) degrees from the Chittagong University of Bangladesh. He is an experienced Clinical Professor in Dermatology and Venereology, with long standing practice in institutional clinical setting and currently serving as Associate Professor in the department of Dermatology and Venereology at CMC, Bangladesh. Professor Mowla is a world-renowned specialist in the care and diagnosis of skin conditions including leprosy. An internationally recognized pioneer in his field and a board certified Dermatologist Dr. Mowla has been practicing medicine since 1992. As a tenure track physician scientist, he has also fostered interdisciplinary education, having been a plenary speaker at both national and international organizations representing dermatology, leprology, venereology, trichology and cosmetology. He currently teaches residents and colleagues as Clinical Professor of Dermatology at the CMC. Dr. Mowla also directs the research part of the department, mentoring multiple postdoctoral fellows, graduate and MD/PhD students, medical students, and undergraduate fellows in his laboratory. The clinic and research sides of the Center are collaborating to initiate clinical trials in patients with autoimmune skin diseases to test drugs that were developed largely based on their preclinical and translational research. He is a premier expert trainer responsible for leading CME courses, training seminars. His work has garnered national and international attention, leading to significant interest in Leprosy, scabies and SLE. Because of his medical expertise, he has been featured on national television networks and on shows. He is widely published and is a sought-after speaker on dermatological matters.
Dr. Mowla boasts a long list of accolades and accreditations for his research and leadership. He has been honored with ‘Global Education Award’ by International Society of Dermatology (ISD), ‘Strauss & Katz Award’ by American Academy of Dermatology (AAD) and World Congress of Dermatology (WCD) 2015 & 2019 Scholarship Award by International League of Dermatological Societies (ILDs). He has co-authored many scientific publications in reputed peer reviewed journals (JAAD, JEADV, IJD, CDJ, STI, CED, Dermatologic Therapy, Forum Dermatologicum and BJDVL etc.) and has been serving as an editorial board member in two national and international journals. He has excellent proven communication skill and a great orator also. He has lectured widely as a featured speaker at many dermatology congresses, and presented many research papers at national and international events like WCD, ICD, AAD, EADV congress. The most sensational and influential researcher Dr. Mowla has presented as an invited speaker at 24th EADV congress 2015, Copenhagen and chaired a session on ‘Leprosy and Leprosy Reactions’ at 75th AAD annual meeting 2017, Orlando and 76th AAD annual meeting 2018, San Diego, USA. Dr. Mowla is recognized as driving force in the study and treatment of collagen vascular diseases, and has done exclusive work in areas related to internal medicine and dermatology. He is a great organizer with penchant excellence. He teamed up with leading experts from home and abroad and social philanthropists to develop ‘Lupus Clinic’ in Bangladesh.
Dr. Mowla leads a broad research program on novel approaches to the prevention and control of poverty-related tropical infectious diseases, particularly leprosy and neglected tropical diseases including scabies. He leads a world-first large community-based trial of mass drug administration for the control of scabies and other neglected tropical diseases. As an expert in tropical dermatology and poverty-related diseases, in the last 20 years he has developed transcultural medicine and helped focus the attention of public and institutions to the health of migrants and the groups at risk of exclusion. He is an author of many publications in national and international scientific journals, original articles, clinical and scientific research studies, epidemiological reports and abstracts presented at national and international congresses.

Dr. Mowla is an exceptional clinician of today in the leprology world. He had made significant contributions to the subspecialty of leprology and certainly exceeded any individual dream in leprology and has extraordinary competence in scientific endeavors. His position as a leader in this growing subspecialty is confirmed by his masterly contribution. A tireless advocate and trailblazer in the study and treatment of all major skin conditions, he is now dedicated to the mission of ‘Leprosy Elimination’ activities having to endure a battle with these distressing skin diseases. Being an excellent organizer, he spent many years identifying and recruiting the most visionary dermatologists to work together. He is one of the pioneers to develop ‘Leprosy Care and Research Group (LCRG)’ in Bangladesh. The main objective of the LCRG is to ensure that physicians become mindful of the life context of health and illness, and become skillful in the habit of humanism, or how to communicate effectively and empathetically to help patients heal. He involves every patient in a highly-inclusive conversation about desires, expectations, realistic results and overall importance of treatment compliance and rehabilitation. He is trying to enhance people’s self-esteem and enrich their lives by giving them added reinforcement and motivation to pursue their goals and dreams and lead a better life. He is highly appreciated amongst his peers for his depth of knowledge, leadership skills and amicable nature.

Dr. Mowla is also active in a number of highly regarded national and international medical groups and is the past Treasurer of the Swadhinata Chikitsak Parishad, Chittagong and Past-Publicity and Public Relation Secretary of the Bangladesh Medical Association, Chittagong. Currently, he is a member of International Affairs Committee of AAD.
Dr. Mowla is passionate about the Internet and its use for diagnostic teledermatology, medical education, and consumer health information. He is excited about the promise of artificial intelligence in widening access to dermatological expertise.

Primary Affiliation: Chittagong Medical College - Chittagong, Chittagong , Bangladesh

Specialties:

Research Interests:


View Mohammad Rafiqul Mowla’s Resume / CV

Education

Jul 2009
Chittagong Medical College
MD (Dermatology)
May 1991
Chittagong Medical College
MBBS

Experience

Jun 2020
Member, Editorial Board
Global Journal of Dermatology
Jun 2020
Member, Editorial Board
Global Journal of Dermatology
Jun 2019
Reviewer
Zagazig University Medical Journal, Egypt
Jun 2019
WCD 2019 Scholarship Award, Milan, Italy
ILDS
Jul 2018
Abstract Mentor
22nd International Conference AIDS 2018 Amsterdam, The Netherlands
Feb 2018
Session Director, ‘Leprosy and Leprosy Reactions’
AAD 2018, San Diego, California, USA.
Mar 2017
Session Director, ‘Leprosy and Leprosy Reactions’
AAD 2017, Orlando, Florida, USA.
Oct 2016
Abstract Reviewer
25th EADV Congress 2016 Vienna, Austria.
May 2016
Abstract Reviewer
13th EADV Spring Symposium 2016 Athens, Greece.
Jan 2016
Member, Editorial Board
Forum Dermatologicum, Poland
Oct 2015
Invited Speaker and Fellowship Award
24th EADV Congress 2015 Copenhagen, Denmark.
Jun 2015
WCD 2015 Scholarship Award, Vancouver, Canada
ILDS
Jun 2014
Reviewer
International Journal of Dermatology
Dec 2013
Global education Award
International Society of Dermatology
Jan 2011
Member, Editorial Board
Journal of the Chittagong Medical College Teachers Association, Bangladesh

Publications

9Publications

101Reads

4Profile Views

A skin disease and needs assessment analysis of the displaced Rohingya population in the Kutupalong refugee camp, Bangladesh

Clinical and Experimental Dermatology A skin disease and needs assessment analysis of the displaced Rohingya population in the Kutupalong refugee camp, Bangladesh DOI:10.1111/ced.14310

Clinical and Experimental Dermatology

Title: A skin disease and needs assessment analysis of the displaced Rohingya population in the Kutupalong refugee camp, Bangladesh

Abstract

The physical, psychological and financial burden of skin disease in low to middle income countries, where access to skincare is limited, is poorly understood. A group that we know very little about in this regard are refugees. There are limited data on the range of skin diseases and skincare needs of this group. To better understand the skincare needs of the displaced Rohingya population, residing in the Kutupalong refugee camp, Bangladesh we collected data on demographics, living conditions and range of dermatoses. Of the 380 patients seen, fungal skin infections, predominantly dermatophytes, were by far the most common skin disease seen (n=219), followed by dermatitis (n=81). Skin disease can be the presenting feature in many systemic conditions and may cause significant secondary complications itself. Developing a better understanding of the skincare needs of the refugee population is essential for future healthcare planning for this vulnerable group.

View Article
June 2020
3 Reads

Efficacy of oral methotrexate (MTX) monotherapy vs oral MTX plus narrowband ultraviolet light B phototherapy in palmoplantar psoriasis

Ara S, Mowla MR, Alam M, Khan I. Efficacy of oral methotrexate (MTX) monotherapy vs oral MTX plus narrowband ultraviolet light B phototherapy in palmoplantar psoriasis. Dermatologic Therapy. 2020;e13486. https://doi.org/10.1111/dth.13486

Dermatologic Therapy

Title: Efficacy of oral methotrexate (MTX) monotherapy vs oral MTX plus narrowband ultraviolet light B phototherapy in palmoplantar psoriasis Abstract Palmoplantar psoriasis (PPP) is a chronic, inflammatory dermatosis of the palms and/or soles with significant morbidity. It is notoriously difficult to treat and unresponsive to traditional topical agents. We aim to compare the effect of oral methotrexate (MTX) monotherapy vs MTX plus narrowband ultraviolet light B (NB‐UVB) in the treatment of recalcitrant PPP. This was a comparative clinical trial involving 90 patients of PPP. Eligible patients were randomly assigned to one of the two treatment groups. We aim patients in group A received 10 mg oral MTX weekly, and patients in group B received oral MTX 10 mg weekly and NB‐UVB sessions twice weekly for 12 weeks. There was a statistically significant difference in reduction of modified PPP Area Severity Index (m‐PPPASI) of patients in MTX plus NB‐UVB at week 12. The mean m‐PPPASI at week 12 was 3.66 ± 2.11 in MTX plus NB‐UVB group and 6.51 ± 2.04 in MTX only group (P  < .001). Marked improvement (m‐PPPASI 75) was achieved in 20 (44.44%) patients in MTX plus NB‐UVB group compared with 6 (13.3%) in MTX monotherapy group (P  < .001). Combination of MTX and NB‐UVB phototherapy helps to attain a better clinical response (reduction in m‐PPPASI score) than MTX monotherapy in the treatment of recalcitrant PPP.

View Article
June 2020
1 Read

Efficacy of oral methotrexate (MTX) monotherapy vs oral MTX plus narrowband ultraviolet light B phototherapy in palmoplantar psoriasis.

Dermatol Ther 2020 May 1:e13486. Epub 2020 May 1.

Department of Pharmacology, Chittagong Medical University, Chittagong, Bangladesh.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.13486DOI Listing
May 2020
1.478 Impact Factor

Leprosy reactions in postelimination stage: the Bangladesh experience

JEADV 2017, 31, 705–711. DOI: 10.1111/jdv.14049

Journal of the European Academy of Dermatology and Venereology

Title: Leprosy reactions in postelimination stage: the Bangladesh experienceAbstractBackground Leprosy reactions are immunologically mediated conditions and a major cause of disability before, duringand after multidrug therapy (MDT). Little data have been published on the epidemiology of leprosy reactions in Bangladesh.Objectives To describe the pattern and prevalence of leprosy reactions in the postelimination stage.Methods A descriptive retrospective cross-sectional study was carried out in Chittagong Medical College Hospitalusing the registered records of patients in the period between 2004 and 2013.Results Of the 670 patients with leprosy, 488 (73.38%) were males and 182 (27.37%) were females. The prevalence ofreaction was in 300 (44.78%) patients with a male:female ratio of 3.55 : 1. The age-specific cumulative reaction cases at>40 years were 115 (38.33%) among all age groups. The prevalence of reaction was found to be in 166 (55.33%) patientsfor the reversal reaction, 49 (16.57%) for the erythema nodosum leprosum (ENL) and 85 (28.33%) for the neuritis. Borderlinetuberculoid was most common (106, 35.33%)in the reversal reaction group, while lepromatous leprosy was mostcommon (37, 12.33%) in ENL group. More than half of the patients (169, 56.33%) had reactions at the time of presentations,while 85 (28.33%) and 46 (15.33%) patients developed reaction during and after MDT, respectively. The reversalreaction group presented with ≥six skin lesions in 96 (57.83%) patients and ≥two nerve function impairments (NFIs) in107 (64.46%) patients. The ENL was present chiefly as papulo-nodular lesions in 45 (91.84%) patients followed by pustule-necrotic lesions in four (8.16%), neuritis in 33 (67.35%), fever in 24 (48.98%), lymphadenitis in six (12.24%), arthritisin five (10.20%) and iritis in two (4.08%). Bacterial index ≥3 had been demonstrated in 34 (60.71%) patients in ENL group.Conclusion The incidence of leprosy reaction seemed to be more than three times common in borderline tuberculoid(52.33%) group than in lepromatous leprosy (14%) group. Reactions with NFI and disability still occur among multibacillarypatients during and after MDT. Early detection and management of leprosy reaction are very important in preventingdisability and deformity, and patients should be educated to undergo regular follow-up examinations. Developing reinforcednew therapies to curb leprosy reactions is crucial for improving leprosy healthcare services.

View Article
May 2017

Recent trends in sexually transmitted infections: the Chittagong, Bangladesh experience.

Sex Transm Infect 2016 08;92(5):349

Department of Medicine, Chittagong Medical College, Chittagong, Bangladesh.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/sextrans-2015-052454DOI Listing
August 2016
1 Read
3.401 Impact Factor

Leprosy profiles in post-elimination stage: a tertiary care hospital experience.

Int J Dermatol 2015 Dec 30;54(12):1407-13. Epub 2015 Jul 30.

Chittagong Leprosy Control Project, Chittagong, Bangladesh.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.12975DOI Listing
December 2015
2 Reads
1.227 Impact Factor

Lysosomal hydrolases of the epidermis. 2. Ester hydrolases.

Br J Dermatol 1975 Oct;93(4):391-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2133.1975.tb06512.xDOI Listing
October 1975
14 Reads
4.275 Impact Factor

Top co-authors

Md Abdus Sattar
Md Abdus Sattar

Chittagong Medical College

1
Sanai Tripura
Sanai Tripura

Chittagong Leprosy Control Project

1
Adam Reich
Adam Reich

Wroclaw Medical University

1
Zygmunt Adamski
Zygmunt Adamski

University School of Poznan

1
Daisuke Tsuruta
Daisuke Tsuruta

Osaka City University Graduate School of Medicine

1
Victoria P Werth
Victoria P Werth

University of Pennsylvania

1
Jacek C Szepietowski
Jacek C Szepietowski

Wroclaw Medical University

1
Carolyn J Kushner
Carolyn J Kushner

University of Pennsylvania

1